Biosplice Therapeutics Patents – Key Insights and Stats

Biosplice Therapeutics has a total of 471 patents globally, out of which 220 have been granted. Of these 471 patents, more than 80% patents are active. Japan is where Biosplice Therapeutics has filed the maximum number of patents, followed by China and Australia. Parallelly, United States of America seems to be the main focused R&D center and also is the origin country of Biosplice Therapeutics.

Biosplice Therapeutics was founded in 2008 by Osman Kibar. Biosplice Therapeutics operates as a biotech company. The Company focuses on osteoarthritis and oncology, with early-stage programs in neurology and other areas. Biosplice Therapeutics serves customers in the United States.

Read about some of the most popular patents of Biosplice Therapeutics which have been covered by us in this article and also you can find Biosplice Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Biosplice Therapeutics patent portfolio.

How many patents does the Founder and CEO of Biosplice Therapeutics have?

The Founder Osman Kibar have 91 patents and the CEO Cevdet Samikoglu have 0 patents.

How many patents does Biosplice Therapeutics have?

Biosplice Therapeutics has a total of 471 patents globally. These patents belong to 81 unique patent families. Out of 471 patents, 379 patents are active.

How Many Patents did Biosplice Therapeutics File Every Year?

Biosplice Therapeutics Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantBiosplice Therapeutics Applications FiledBiosplice Therapeutics Patents Granted
201118
201233
201367
2014631
2015558
20164514
20177033
20183543
20193552
2020738
2021517
202214

How many Biosplice Therapeutics patents are Alive/Dead?

Worldwide Patents

Biosplice Therapeutics Patents Portfolio

How Many Patents did Biosplice Therapeutics File in Different Countries?

Biosplice Therapeutics worldwide Patents

Countries in which Biosplice Therapeutics Filed Patents

CountryPatents
Japan24
China18
Australia18
Canada18
Mexico17
Singapore17
Chile16
Hong Kong (S.A.R.)16
India15
Brazil15
Korea (South)14
Indonesia14
Europe14
Israel14
Philippines13
Malaysia12
Germany12
New Zealand11
Denmark10
Kazakhstan10
Spain9
Albania9
Poland8
Slovenia8
Portugal8
Croatia8
Peru8
Hungary7
Serbia7
Lithuania7
Morocco6
United States Of America4
Colombia4
Russia4
Macao4
Montenegro4
Cyprus4
Viet Nam3
United Arab Emirates3
Argentina2
Turkey1
Eurasia1
South Africa1
San Marino1

Where are Research Centers of Biosplice Therapeutics Patents Located?

Research Centers of Biosplice Therapeutics Patents

10 Best Biosplice Therapeutics Patents

US20110034441A1 is the most popular patent in the Biosplice Therapeutics portfolio. It has received 144 citations so far from companies like Samumed Llc, Merck Patent Gmbh and Epitherix Llc.

Below is the list of 10 most cited patents of Biosplice Therapeutics:

Publication NumberCitation Count
US20110034441A1144
WO2011084486A1127
WO2017079765A146
WO2013040215A142
WO2013151708A121
WO2015143380A119
WO2012024404A118
WO2017023972A117
WO2017189829A116
WO2014130869A116

What Percentage of Biosplice Therapeutics US Patent Applications were Granted?

Biosplice Therapeutics (Excluding its subsidiaries) has filed 96 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 85 have been granted leading to a grant rate of 98.8%.

Below are the key stats of Biosplice Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Biosplice Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Fish & Richardson Pc9698.84%

EXCLUSIVE INSIGHTS COMING SOON!

What are Biosplice Therapeutics key innovation segments?

What Technologies are Covered by Biosplice Therapeutics?

The chart below distributes patents filed by Biosplice Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Biosplice Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Biosplice Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Biosplice Therapeutics?

Table of Content

Insights you may find interesting

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.